Gordofilm Wart Remover (salicylic acid 16.7% USP) packaged in 15 cc glass jars, Gordon Laboratories, Upper Darby PA 19082, NDC 10481-3009-01
Dercher Enterprises, Inc.
cGMP Deviations
💊 Drugs • 3,313 recalls
Dercher Enterprises, Inc.
cGMP Deviations
Pyramids Wholesale
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Aruba Aloe Balm N.V.
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Pyramids Wholesale
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Pyramids Wholesale
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Pyramids Wholesale
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Pyramids Wholesale
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Pyramids Wholesale
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Pyramids Wholesale
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
CGMP Deviations
Pyramids Wholesale
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Apothecus Pharmaceutical
cGMP Diviations
Super Chill Products
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Optikem International
Lack of Assurance of Sterility
Contract Pharmaceuticals Limited Canada
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Lack of Assurance of Sterility
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.